Select Medical (SEM) reported Q1 earnings from continuing operations late Thursday of $0.44 per diluted share, up from $0.33 a year earlier.
Analysts polled by FactSet expected $0.46.
Revenue for the quarter ended March 31 was $1.35 billion compared with $1.32 billion a year earlier.
Analysts surveyed by FactSet expected $1.39 billion.
The company reaffirmed its 2025 earnings of $1.09 to $1.19 per diluted share. Analysts surveyed by FactSet expect $1.12. The company Trimmed annual revenue guidance to $5.3 billion to $5.5 billion from $5.4 billion to $5.6 billion. Analysts polled by FactSet expect $5.46 billion.
Shares of the company fell more than 3% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.